Pulsatile Hemodynamics in Congestive Heart Failure
暂无分享,去创建一个
M. Pfeffer | J. Tardif | G. Mitchell | G. Marchiori | J. Arnold | M. Dunlap | M A Pfeffer | G F Mitchell | J C Tardif | J M Arnold | G Marchiori | T X O'Brien | M E Dunlap | T. O'Brien
[1] G Fontenier,et al. Aortic input impedance in heart failure: comparison with normal subjects and its changes during vasodilator therapy. , 1984, European heart journal.
[2] G. Riegger,et al. Aortic input impedence and neurohormonal activation in patients with mild to moderate chronic congestive heart failure. , 1992, Cardiovascular research.
[3] B. Wilcox,et al. Comparison of time domain algorithms for estimating aortic characteristic impedance in humans , 1988, IEEE Transactions on Biomedical Engineering.
[4] W. Nichols,et al. Aortic Input Impedance in Heart Failure , 1978, Circulation.
[5] J. Polak,et al. Carotid arterial compliance in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. , 1994, The American journal of cardiology.
[6] M. Pfeffer,et al. Measurement of aortic input impedance in rats. , 1994, The American journal of physiology.
[7] M. O'Rourke,et al. Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. , 1986, Cardiovascular research.
[8] S. Solomon,et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. , 1992, Journal of the American College of Cardiology.
[9] M. Pfeffer,et al. Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats. , 1996, Circulation.
[10] R. Busse,et al. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. , 1999, Circulation.
[11] L A Moyé,et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. , 1997, Circulation.
[12] D. Harrison,et al. Increased superoxide in heart failure: a biochemical baroreflex gone awry. , 1999, Circulation.
[13] D. Fitchett,et al. Noninvasive determination of aortic input impedance and external left ventricular power output: a validation and repeatability study of a new technique. , 1992, Journal of the American College of Cardiology.
[14] M. Mulvany,et al. Reduced vasodilator capacity in syndrome X related to structure and function of resistance arteries. , 1999, The American journal of cardiology.
[15] N. Westerhof,et al. An artificial arterial system for pumping hearts. , 1971, Journal of applied physiology.
[16] K P Brin,et al. Estimation of total arterial compliance: an improved method and evaluation of current methods. , 1986, The American journal of physiology.
[17] A Noordergraaf,et al. Apparent arterial compliance. , 1998, The American journal of physiology.
[18] M. Pfeffer,et al. Comparison of techniques for measuring pulse-wave velocity in the rat. , 1997, Journal of applied physiology.
[19] N. Westerhof,et al. Forward and backward waves in the arterial system. , 1972, Cardiovascular research.
[20] R J Glynn,et al. Increased pulse pressure and risk of heart failure in the elderly. , 1999, JAMA.
[21] W. Laskey,et al. Characteristics of vascular hydraulic load in patients with heart failure. , 1985, Circulation.
[22] K. Pritchard,et al. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. , 1996, Circulation research.
[23] N Westerhof,et al. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. , 1995, Journal of hypertension.
[24] R. Ferrari,et al. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. , 1999, Circulation.
[25] M. Pfeffer,et al. Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators. , 1999, Journal of cardiac failure.
[26] S. Yusuf,et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.
[27] N. Westerhof,et al. Aortic Input Impedance in Normal Man: Relationship to Pressure Wave Forms , 1980, Circulation.
[28] C. Jones,et al. Endothelial control of arterial distensibility is impaired in chronic heart failure. , 1995, Circulation.
[29] M. Pfeffer,et al. Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. , 1999, Journal of the American College of Cardiology.